| Person Name | Explanation |
|---|---|
| JOHN K GARVEY |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BUILDERS INDEX FDS TR EMG MKTS 50 | 15,886 | 14,299 |
| COLUMBIA GLOBAL VALUE | 25,138 | 18,934 |
| EATON VANCE WORLDWIDE HEALTH | 8,488 | 11,929 |
| FRANKLIN BIOTECHNOLOGY DISCOVERY-SA | 64,841 | 86,964 |
| FRANKLIN RISING DIVIDENDS CL C | 21,315 | 36,267 |
| INDEXIQ ETF TR IQ HEDGE MULTI | 4,065 | 4,288 |
| ING VALUE CHOICE FUND CL A | 24,401 | 28,770 |
| ISHARES TR MSCI EMERGING MKTS | 84,706 | 90,361 |
| LORD ABBETT ALL VALUE | 21,212 | 34,519 |
| LORD ABBETT MID-CAP VALUE | 30,604 | 41,208 |
| MFS VALUE FUND | 18,298 | 34,719 |
| MUTUAL SERIES | 15,820 | 21,460 |
| TEMPLETON FOREIGN | 35,714 | 24,959 |
| TEMPLETON SMALL CO | 58,531 | 63,840 |
| THIRD AVENUE SMALL CAP VALUE | 18,242 | 31,223 |
| AMERICAN CAPITAL AGENCY CORP | 33,389 | 18,229 |
| CHIMERA INVT CORP | 32,398 | 37,622 |
| INVESCO BALANCED RISK FUND CL A | 16,232 | 15,360 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ACCRUED DIVIDENDS | 2,275 | 1,707 | 1,707 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| SUPPLIES | 575 | 575 | ||
| DUES & SUBSCRIPTIONS | 62 | 62 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| UNCLEARED CONTRIBUTIONS | 1,100 | ||
| RECONCILIATION DISCREPANCIES | 128 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 458 | 458 |